Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-314,468
Closed -$626K 3659
2025
Q2
$626K Sell
314,468
-10,016
-3% -$18.3K ﹤0.01% 2338
2025
Q1
$471K Sell
324,484
-96,066
-23% -$178K ﹤0.01% 2518
2024
Q4
$871K Buy
420,550
+104,001
+33% +$195K ﹤0.01% 2317
2024
Q3
$557K Buy
316,549
+4,901
+2% +$12.6K ﹤0.01% 2405
2024
Q2
$4.51M Buy
311,648
+2,344
+0.8% +$32.2K ﹤0.01% 1290
2024
Q1
$5.14M Buy
309,304
+198,985
+180% +$3.18M ﹤0.01% 1259
2023
Q4
$1.77M Buy
110,319
+100,055
+975% +$1.33M ﹤0.01% 1738
2023
Q3
$138K Sell
10,264
-98,710
-91% -$1.39M ﹤0.01% 3008
2023
Q2
$1.87M Buy
108,974
+98,198
+911% +$1.52M ﹤0.01% 1657
2023
Q1
$178K Buy
10,776
+3,252
+43% +$52K ﹤0.01% 3062
2022
Q4
$126K Buy
7,524
+2,265
+43% +$40.9K ﹤0.01% 3222
2022
Q3
$90K Sell
5,259
-868
-14% -$12.6K ﹤0.01% 3370
2022
Q2
$67K Buy
+6,127
New +$72.8K ﹤0.01% 3671

Deutsche Bank's HLVX Position: Q3 2025 in Review

Deutsche Bank sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 314,468 shares — an estimated $626K sold.

Deutsche Bank first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $5.14M in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Deutsche Bank reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Deutsche Bank sold 314,468 HilleVax shares in Q3 2025, an estimated $626K.
  • Deutsche Bank first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
  • Deutsche Bank's HilleVax position peaked at $5.14M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.